Showing items related by title, author, creator and subject.

• Post-synthetically elaborated BODIPY-based porous organic polymers (POPs) for the photochemical detoxification of a sulfur mustard simulant 

  Authors:Çetin, M. Mustafa; Atılgan, Ahmet; Beldjoudi, Yassine; Liu, Jian; Stern, Charlotte L.; Çetin, Furkan M.; İslamoğlu, Timur; Farha, Omar K.; Deria, Pravas; Stoddart, Frasser J.; Hupp, Joseph T.
  Publisher and Date:(American Chemical Society, 2020)

  Designing new materials for the effective detoxification of chemical warfare agents (CWAs) is of current interest given the recent use of CWAs. Although halogenated borondipyrromethene derivatives (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene or BDP or BODIPY) at the 2 and 6 positions have been extensively explored as efficient photosensitizers for generating singlet oxygen (1 O2) in homogeneous media, their utilization in the design of porous organic polymers (POPs) has remained elusive due to the ...

  
  
• Acute myeloblastic leukemia achieving complete remission with Amifostine alone 

  Authors:Öztürk, Ahmet Kutlu; Orhan, Bülent; Türken, Orhan; Etiz, Durmuş; Yaylacı, Mustafa; Üskent, Necdet
  Publisher and Date:(2002)

  Amifostine, a phosphorylated thiol-amine, is known as a cytoprotective agent especially for cisplatin containing chemotherapies. Apart from the cytoprotective role, Amifostine could also be used in the treatment of hematologic malignancies such as myelodysplastic syndrome (MDS) and acute myeloblastic leukemia (AML), as a treatment option or for potentiating the effects of cytotoxic agents. We tried to use Amifostine in a patient with AML, which did not respond to conventional cytotoxic chemotherapy ...

  
  
• 

  Posterior vitrectomy under topical anesthesia 

  Authors:Bahçecioǧlu, Halil Ibrahim; Ünal, Mustafa; Artunay, Özgür; Rasier, Rifat; Sarıcı, Ahmet Murat
  Publisher and Date:(Elsevier, 2007)

  Background: To determine the safety and efficacy of topical anesthesia in posterior vitrectomy. Methods: A total of 93 patients (93 eyes) with various vitreoretinal diseases not needing scleral buckling and with short predicted duration of surgery underwent posterior vitrectomy under topical (49 eyes) or retrobulbar (44 eyes) anesthesia. Patients in the topical group were sedated with neuroleptic anesthesia. Postoperatively patients were shown a visual analogue pain scale (VAPS) from 0 (no pain) ...